S. Coll

6.6k total citations · 1 hit paper
44 papers, 4.3k citations indexed

About

S. Coll is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, S. Coll has authored 44 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 32 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in S. Coll's work include Liver Disease Diagnosis and Treatment (29 papers), Liver Disease and Transplantation (18 papers) and Hepatitis C virus research (15 papers). S. Coll is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Liver Disease and Transplantation (18 papers) and Hepatitis C virus research (15 papers). S. Coll collaborates with scholars based in Spain, Czechia and India. S. Coll's co-authors include Ricard Solà, Ramón Planas, Jordi Bruix, Jordi Muchart, María Sala, Josep M. Llovet, María Isabel Real, Carmen Ayuso, Joan Rodés and Xavier Montañá and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

S. Coll

44 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

2002 2.7k citations Josep M. Llovet, María Isabel Real et al. The Lancet profile →

Peers

Countries citing papers authored by S. Coll

Since Specialization

Citations

This map shows the geographic impact of S. Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Coll more than expected).

Fields of papers citing papers by S. Coll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Coll. The network helps show where S. Coll may publish in the future.

Co-authorship network of co-authors of S. Coll

This figure shows the co-authorship network connecting the top 25 collaborators of S. Coll. A scholar is included among the top collaborators of S. Coll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Coll. S. Coll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients 2020 ·World Journal of Hepatology ·(unknown), Montserrat Garcı́a-Retortillo, (unknown), (unknown), Marc Puigvehí, Núria Cañete, S. Coll, (unknown), (unknown), Xavier Bessa, J.A. Carrión	12
2	Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues 2017 ·PLoS ONE ·(unknown), Montserrat Garcı́a-Retortillo, (unknown), Marc Puigvehí, Núria Cañete, S. Coll, (unknown), (unknown), Ricard Solà, J.A. Carrión	11
3	Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years 2016 ·PLoS ONE ·Marc Puigvehí, (unknown), (unknown), S. Coll, Montserrat Garcı́a-Retortillo, Núria Cañete, (unknown), M. García García, Felipe Bory, Margarita Salvadó, Ricard Solà, J.A. Carrión	11
4	Evaluación y tratamiento del paciente cirrótico crítico 2016 ·Gastroenterología y Hepatología ·Javier Fernández, Carles Aracil, Elsa Solà, Germán Soriano, (unknown), S. Coll, Joan Genescà, (unknown), Rosa M. Morillas, Marta Martín–Llahí, Albert Pardo, Jordi Sánchez‐Delgado, Vı́ctor Vargas, Xavier Xiol, Pere Ginès	9
5	Drug–drug interactions of telaprevir and boceprevir in HCV ‐monoinfected and HIV / HCV ‐coinfected patients can modify the adherence 2014 ·Liver International ·(unknown), (unknown), (unknown), Montserrat Garcı́a-Retortillo, Núria Cañete, S. Coll, (unknown), (unknown), (unknown), Felipe Bory, Hernando Knobel, E. Salas, Ricard Solà, J.A. Carrión	5
6	A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C 2013 ·Journal of Hepatology ·J.A. Carrión, (unknown), Montserrat Garcı́a-Retortillo, Núria Cañete, Isabel Cirera, S. Coll, (unknown), Carmen Márquez, (unknown), Pere Castellví, Ricard Navinés, (unknown), (unknown), E. Salas, Felipe Bory, Rocı́o Martı́n-Santos, Ricard Solà	27
7	Incidence and Prognosis of Different Types of Functional Renal Failure in Cirrhotic Patients With Ascites 2010 ·Clinical Gastroenterology and Hepatology ·Silvia Montoliu, Belén Ballesté, Ramón Planas, Marco Antonio Álvarez, Mònica Rivera, Mireia Miquel, Helena Masnou, Isabel Cirera, Rosa M. Morillas, S. Coll, (unknown), Montserrat Garcı́a-Retortillo, Núria Cañete, Ricard Solà	65
8	Poor Response to Hepatitis C Virus (HCV) Therapy in HIV- and HCV-Coinfected Patients Is Not Due to Lower Adherence to Treatment 2006 ·AIDS Research and Human Retroviruses ·Ricard Solà, (unknown), Silvia Montoliu, Cristina Tural, Lluís Force, (unknown), (unknown), (unknown), S. Coll, Daniel Fuster, Pilar Barrufet, Guillem Sirera, (unknown), Bonaventura Clotet, Ramón Planas	20
9	Natural History of Patients Hospitalized for Management of Cirrhotic Ascites 2006 ·Clinical Gastroenterology and Hepatology ·Ramón Planas, Silvia Montoliu, Belén Ballesté, Mònica Rivera, Mireia Miquel, Helena Masnou, (unknown), (unknown), Justiniano Santos, Isabel Cirera, Rosa M. Morillas, S. Coll, Ricard Solà	270
10	Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients 2004 ·Journal of Hepatology ·Ramón Planas, Belén Ballesté, Marco Antonio Álvarez, Mònica Rivera, Silvia Montoliu, (unknown), Justiniano Santos, S. Coll, Rosa M. Morillas, Ricard Solà	233
11	Mechanisms of early decrease in systemic vascular resistance after total paracentesis 2004 ·European Journal of Gastroenterology & Hepatology ·S. Coll, Maria Carme Vila, Lluís Molina Balaguer, (unknown), Carlos Guarner, (unknown)	21
12	Paracentesis with low flow-rate extraction of ascites: Control study 2003 ·Journal of Hepatology ·S. Coll, Marta Piqueras, (unknown), (unknown), Maria Carme Vila, Xavier Torras, Carlos Guarner, R. Solà	1
13	Hipertensión portal idiopática asociada a esclerosis sistémica progresiva 2002 ·Carolina Pérez-García, S. Coll, (unknown)	2
14	Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial breakdown → 2002 ·The Lancet ·Josep M. Llovet, María Isabel Real, Xavier Montañá, Ramón Planas, S. Coll, (unknown), Carmen Ayuso, María Sala, Jordi Muchart, Ricard Solà, Joan Rodés, Jordi Bruix	2669
15	Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C 2000 ·Journal of Hepatology ·M. Guilera, Xavier Forns, Xavier Torras, Jaime Enríquez, S. Coll, Ricard Solà, Rosa M. Morillas, Ramón Planas, Sergi Ampurdanés, Marta Soler, (unknown), Juan‐Carlos Sáiz, (unknown), Juan Rodés	13
16	Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels 1999 ·Gastroenterology ·Carlos Guarner, (unknown), Germán Soriano, (unknown), (unknown), (unknown), M Sàbat, S. Coll, (unknown), (unknown), (unknown)	8
17	Total Paracentesis in Cirrhotic Patients With Tense Ascites and Dilutional Hyponatremia 1999 ·The American Journal of Gastroenterology ·Maria Carme Vila, S. Coll, Ricard Solà, Montserrat Andreu, Jordi Gana, J. Marquez	12
18	Infections Caused By Escherichia Coli Resistant to Norfloxacin in Hospitalized Cirrhotic Patients 1999 ·Hepatology ·Jordí Ortiz, Maria Carme Vila, Germán Soriano, Josep Miñana, Jordi Gana, Beatriz Mirelis, María Novella, S. Coll, M Sàbat, Montserrat Andreu, Guillem Prats, Ricard Solà, Carlos Guarner	103
19	Hemodynamic changes in patients developing effective hypovolemia after total paracentesis 1998 ·Journal of Hepatology ·Maria Carme Vila, Ricard Solà, Lluís Molina Balaguer, Montserrat Andreu, S. Coll, Jordi Gana, J. Marquez, (unknown), Felipe Bory, (unknown), (unknown), Wladimiro Jiménez	47
20	Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study 1994 ·Journal of Hepatology ·Ricard Solà, (unknown), Montserrat Andreu, María Oliver-Ferrándiz, S. Coll, Jordi Gana, (unknown), Pere Ginès, Wladimiro Jiménez, Vicente Arroyo	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact